A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
Enrolling by invitation · NCT07633197 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) | DNA Virus Infections, Herpesviridae infectious disease, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, herpes simplex infectious disease, skin disorder, skin disorder caused by infection, viral infectious disease | Enrolling by invitation | Phase 1 | 2026-06-08 | NCT07633197 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changchun BCHT Biotechnology Co. | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan CDC | Zhengzhou | China | 1 |